RSP Systems awarded €2.4m grant for non-invasive blood glucose measurement technology

adminOdense Health

rsp

RSP Systems (Odense), the Danish biotechnology company that specialises in non-invasive human diagnostics, has been awarded a €2.4m grant under the EU’s Horizon 2020 framework for research and innovation, writes BBH on their webpage

The funds will be used to take GlucoBeam, the world’s first accurate, non-invasive glucose monitor for diabetic patients, through to market launch.

‘This vital grant will help to overcome the biggest issue in glucose monitoring: compliance. For patients to finally be able to measure their glucose levels using the non-invasive GlucoBeam will be a real breath of fresh air,’ said Dr Anders Weber, CEO of RSP Systems.